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AbstrAct
Objective
To assess whether severe psychiatric reactions to 
trauma and other adversities are associated with 
subsequent risk of life threatening infections.
Design




144 919 individuals with stress related disorders 
(post-traumatic stress disorder (PTSD), acute stress 
reaction, adjustment disorder, and other stress 
reactions) identified from 1987 to 2013 compared 
with 184 612 full siblings of individuals with a 
diagnosed stress related disorder and 1 449 190 
matched individuals without such a diagnosis from 
the general population.
Main OutcOMe Measures
A first inpatient or outpatient visit with a primary 
diagnosis of severe infections with high mortality 
rates (ie, sepsis, endocarditis, and meningitis or 
other central nervous system infections) from the 
Swedish National Patient Register, and deaths from 
these infections or infections of any origin from the 
Cause of Death Register. After controlling for multiple 
confounders, Cox models were used to estimate 
hazard ratios of these life threatening infections.
results
The average age at diagnosis of a stress related 
disorder was 37 years (55 541, 38.3% men). During 
a mean follow-up of eight years, the incidence of life 
threatening infections per 1000 person years was 
2.9 in individuals with a stress related disorder, 1.7 
in siblings without a diagnosis, and 1.3 in matched 
individuals without a diagnosis. Compared with 
full siblings without a diagnosis of a stress related 
disorder, individuals with such a diagnosis were at 
increased risk of life threatening infections (hazard 
ratio for any stress related disorder was 1.47 (95% 
confidence intervals1.37 to 1.58) and for PTSD was 
1.92 (1.46 to 2.52)). Corresponding estimates in the 
population based analysis were similar (1.58 (1.51 
to 1.65) for any stress related disorder, P=0.09 for 
difference between sibling and population based 
comparison, and 1.95 (1.66 to 2.28) for PTSD, 
P=0.92 for difference). Stress related disorders 
were associated with all studied life threatening 
infections, with the highest relative risk observed 
for meningitis (sibling based analysis 1.63 (1.23 to 
2.16)) and endocarditis (1.57 (1.08 to 2.30)). Younger 
age at diagnosis of a stress related disorder and 
the presence of psychiatric comorbidity, especially 
substance use disorders, were associated with higher 
hazard ratios, whereas use of selective serotonin 
reuptake inhibitors in the first year after diagnosis 
of a stress related disorder was associated with 
attenuated hazard ratios.
cOnclusiOn
In the Swedish population, stress related disorders 
were associated with a subsequent risk of life 
threatening infections, after controlling for familial 
background and physical or psychiatric comorbidities.
Introduction
Excessive or prolonged psychological stress com­
promises several physiological systems, which might 
increase susceptibility to disease.1 Strong evidence 
from animal models2 and human studies1 3 suggests 
a considerable modulation of the hypothalamic­
pituitary­adrenal axis in response to stress, with 
altered biological functions such as compromised 
immunity (eg, impaired humoral and cell mediated 
immunity)1 and increased inflammatory reactivity.1 
Correspondingly, people exposed to psychological 
stress have been reported to have a higher risk of 
respiratory virus infections4­6 paralleled with reduced 
immune responses to several antiviral and antibacterial 
vaccines.7­10
Stress related disorders, including post­traumatic 
stress disorder (PTSD), acute stress reaction (also 
known as acute stress disorder), adjustment disorder, 
and other stress reactions, refer to a group of psy­
chiatric conditions that are preceded and triggered by 
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WhAt Is AlreAdy knoWn on thIs topIc
Psychological stress might increase susceptibility to infections through 
compromised immunity
A series of experimental studies on humans and other animals suggests a link 
between psychological stress and acute respiratory tract infections
Data are, however, limited on more severe life threatening infections such as 
meningitis and sepsis
WhAt thIs study Adds
This study found an association between stress related disorders and risk of life 
threatening infections, including sepsis, endocarditis, central nervous system 
infections, and fatal infections of any other origin
The association was more pronounced among people with a diagnosed stress 
related disorder at a younger age and those with psychiatric comorbidities
The long term use of selective serotonin reuptake inhibitors was associated with 
an attenuated risk of life threatening infections after diagnosis of a stress related 
disorder
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an identifiable trauma or other life stressors.11 With 
considerable variation in response to adverse events, 
people with stress related disorders might represent 
a population with the most severe physiological 
dysregulation as a result of severe stress.1 Indeed, 
disrupted immune profiles have been reported in 
populations with PTSD and other stress related 
disorders1 12­14 as well as an increased risk of various 
autoimmune diseases.15 Recent data suggest an 
association between PTSD and a number of infectious 
diseases,16 although data are as yet scarce on the role 
of stress­related disorder in major life threatening 
infections. Taking advantage of nationwide registers 
in Sweden, with complete information on medical 
diagnoses and family links, we conducted a population 
based sibling controlled cohort study to explore the 
association between stress related disorders and risk 
of life threatening infections.
Methods
study design
From the Swedish National Patient Register we identi­
fied all Sweden born residents with a first diagnosis 
of a stress related disorder between 1 January 1987 
and 31 December 2013 (n=156 537). This register 
contains nationwide data on inpatient care from 1987 
and specialist outpatient care from 2001. Utilising 
the national identification numbers that are uniquely 
assigned to all Swedish residents, we linked the cohort 
with stress related disorders to other health registers 
in Sweden.
We excluded those with a diagnosis of a stress rela­
ted disorder at age 5 or younger (n=139),17 a history 
of any life threatening infection before the diagnosis 
of a stress related disorder (n=4311), conflicting 
information (died or emigrated before the diagnosis, 
n=24), or missing information on county of birth 
(n=21). To ensure complete family links from the 
Swedish Multi­Generation Register,18 we further 
excluded 7123 people born before 1932, leaving 
144 919 people for analysis. The date of diagnosis was 
the index date.
sibling cohort
To control for familial confounding,17 we constructed 
a sibling cohort to compare individuals with a stress 
related disorder with their unaffected full siblings. 
Through the Multi­Generation Register, we identified 
184 612 full siblings (of 103 072 (71.1%) individuals 
with a stress related disorder) without a diagnosis of 
a stress related disorder or life threatening infection 
at the diagnosis date of the affected sibling (ie, index 
date).
Population matched cohort
A matched cohort design was used to compare indivi­
duals with a stress related disorder with the general 
population. For each individual with a stress related 
disorder diagnosis, we then randomly selected 10 
people from the Total Population Register with no 
diagnosis of a stress related disorder or life threatening 
infection at the diagnosis date of the affected individual 
(ie, index date). We individually matched individuals 
without a diagnosis of stress related disorder to 
individuals with such a diagnosis by sex, birth year, 
and county of birth.
Follow-up
Follow­up of the study cohorts started from the index 
date until the occurrence of any or a specific type of life 
threatening infection, death, emigration, or the end of 
follow­up (31 December 2013), whichever occurred 
first. The follow­up for unaffected full siblings or 
individuals without a diagnosis of stress related 
disorder was additionally censored if a stress related 
disorder was diagnosed after the index date.
stress related disorders
We defined stress related disorders as any first 
inpatient or outpatient visit with the main diagnosis 
of a stress related disorder registered in the National 
Patient Register according to ICD­9 (international 
classification of diseases, ninth revision) codes 308 
or 309 and ICD­10 (10th revision) code F43. Stress 
related disorders were further divided into PTSD (ICD­
9: 309B; ICD­10: F43.1), acute stress reaction (ICD­9: 
308, 309A; ICD­10: F43.0), and adjustment disorder 
and other stress reactions (ICD­9: 309X; ICD­10: F43.8, 
F43.9, see supplementary table 1). Because PTSD 
might initially be diagnosed as other stress related 
disorders (eg, acute stress reaction19), we considered 
individuals with a PTSD diagnosis within one year 
after their first stress related disorder diagnosis to have 
had a PTSD diagnosis from the date of first diagnosed 
stress related disorder.
From the Swedish Prescribed Drug Register (July 
2005 onwards) we obtained information on prescribing 
of selective serotonin reuptake inhibitors (Anatomical 
Therapeutic Chemical code N06AB) within the first year 
after the diagnosis of a stress related disorder. Although 
the use of selective serotonin reuptake inhibitors in 
children and young people is debatable,20 this drug 
class has been widely used21 and recommended as 
the first line pharmacotherapy for adults with stress 
related disorders (for example, in Sweden,22 United 
Kingdom,23 and United States24). We defined users of 
selective serotonin reuptake inhibitors as those with 
two or more dispensations of this drug. We calculated 
the average dosage by dividing the cumulative defined 
daily dose by the interval (days) from the first to the last 
dispensation; and this interval was also considered as 
the length of selective serotonin reuptake inhibitors 
treatment.
life threatening infections
We identified incident cases of severe infections 
characterised by high fatality (sepsis, endocarditis, 
and meningitis or other central nervous system 
infections) as any first inpatient or outpatient visit with 
these infections as the main diagnosis, or death with 
these infections as the underlying cause of death from 
the Cause of Death Register. In addition, we identified 
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all lethal infections of any other origin by identifying 
deaths with other infections documented as the 
underlying cause of death from the Cause of Death 
Register (see supplementary table 1).
covariates
Data on education level, family income, and marital 
status were obtained from the Longitudinal Integration 
Database for Health Insurance and Labour Market study 
database. Other psychiatric disorders are commonly 
diagnosed around the same time as diagnosis of 
stress related disorders.25 26 Given that co­occurring 
psychiatric disorders might also be related to the trauma 
preceding the diagnosis of stress related disorder, and 
as such represent more severe stress reactions, we 
considered other psychiatric diagnoses from three 
months before to one year after the diagnosis of stress 
related disorder as psychiatric comorbidity. In contrast, 
we considered other psychiatric disorders documented 
more than three months before the diagnosis of a 
stress related disorder as indicating a history of other 
psychiatric disorders. We further obtained information 
on history of severe somatic diseases (myocardial 
infarction, congestive heart failure, cerebrovascular 
disease, chronic pulmonary disease, connective tissue 
disease, diabetes, renal diseases, liver diseases, ulcer 
diseases, and HIV infection/AIDS),27 and history of 
inpatient visit because of any infectious disease (as 
an indicator of baseline susceptibility to infectious 
diseases). The diagnoses were obtained from the 
National Patient Register, with corresponding ICD 
codes (see supplementary table 1). Family history of 
major life threatening infections was defined as any 
diagnosis of or death due to sepsis, endocarditis, and 
meningitis or other central nervous system infections 
among biological parents and full siblings of the 
study individuals, according to the National Patient 
Register or the Cause of Death Register. Except for the 
categories of history of other psychiatric disorder and 
of psychiatric comorbidity, we updated information 
until the index date (baseline) for all other covariates. 
For sensitivity analyses on somatic comorbidities and 
behaviour related factors, data on the presence of 
severe somatic diseases and substance use or sleep 
related diseases (see supplementary table 1) after 
the index date were also extracted from the National 
Patient Register. Anatomical defects (congenital 
diseases of heart and nervous system) are risk factors 
for severe infections,28 and therefore were identified 
from the National Patient Register and Medical Birth 
Register (available from 1973 onwards).
statistical analysis
We estimated the association between stress related 
disorders and risk of life threatening infections using 
hazard ratios with 95% confidence intervals, derived 
from conditional Cox regression models. Time since the 
index date was applied as the underlying time scale.
In the sibling cohort, all models were stratified 
by family identifier and adjusted for sex, birth year, 
education level (<9 years, 9­12 years, >12 years, 
unknown), family income (top 20%, middle, lowest 
20%, unknown), marital status (single, married or 
cohabiting, divorced or widowed), history of severe 
somatic diseases (yes or no), history of other psychiatric 
disorders (yes or no), and history of inpatient visit 
because of any infectious diseases (yes or no). We first 
considered stress related disorders as one group and 
then by diagnostic categories of PTSD, acute stress 
reaction, and adjustment disorder and other stress 
reactions. Also, in addition to a diagnosis of any life 
threatening infection, we separately examined the 
risk of sepsis, endocarditis, and meningitis or, other 
central nervous system infections, and deaths due to 
infections of any other origin.
In subgroup analyses, we calculated the hazard 
ratios by sex (men or women), time since index date 
(<1 year, 1­4 years, 5­9 years, or ≥10 years), history of 
severe somatic diseases (yes or no), calendar period 
at the index date (1987­2000, 2001­05, or 2006­13), 
history of other psychiatric disorders (yes or no), family 
history of major life threatening infections (yes or no), 
and history of inpatient visit because of any infectious 
diseases (yes or no). The differences of subgroup 
hazard ratios were assessed by introducing interaction 
terms to the Cox models or by computing Wald tests. 
In addition, to examine potential effect modification 
by age at index date on the interested association, we 
applied restricted cubic splines on age and integrated 
these to the Cox models by adding an interaction 
term.29 Age varying hazard ratios were estimated and 
visualised thereafter.
To study the potential impact of severity and 
complexity of stress related disorders on the studied 
associations, we assessed hazard ratios by the pre­
sence of psychiatric comorbidity (any psychiatric 
comorbidity, as well as by specific type, including 
depression, anxiety, and substance use disorders) and 
by the type of psychiatric care received at diagnosis 
(inpatient or outpatient care). Within one year after the 
diagnosis of a stress related disorder, we considered 
the psychiatric comorbidity as a time varying variable.
We repeated the main analyses in the population 
based cohort, where we used conditional Cox models 
stratified by matching identifiers (sex, birth year, 
and county of birth), adjusting for family history of 
major life threatening infections (yes or no) and all 
other covariates. We compared hazard ratios between 
sibling and population based analyses using a z test.30 
Furthermore, we restricted analyses to individuals 
with a diagnosis of a stress related disorder after July 
2005 and with more than one year of follow­up, and 
compared the risk of life threatening infections beyond 
one year between subgroups with different status of 
selective serotonin reuptake inhibitors use.
To test the robustness of the observed associations, 
we performed several sensitivity analyses. To rule 
out the possibility that the observed risk increase 
was due to a pre­existing or co­occurring medical 
condition, we excluded from the analysis individuals 
with any diagnosis of severe somatic diseases, injuries 
and poisonings, or infectious diseases (see codes in 
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supplementary table 1) within one year before the 
index date. In addition, to alleviate concerns that 
the observed associations were accounted for by the 
poorer health conditions or suboptimal behaviours 
of individuals with stress related disorders than those 
without, we restricted our analyses to individuals 
without a history of severe somatic diseases and 
additionally adjusted the Cox models by the presence 
of severe somatic conditions (as time varying variables) 
or substance use or sleep related diagnoses (as a 
binary variable) during follow­up. Lastly, to account 
for increased risk of infection from anatomical defects, 
we repeated our analyses after excluding those with 
congenital heart or nervous system diseases. Analyses 
were conducted in SAS statistical software, version 9.4 
(Cary, NC) and STATA 15 (StataCorp).
Patient and public involvement
No patients were involved in proposing the research 
question or the outcome measures, nor were they 
involved in developing plans for design or imple­
mentation of the study. There are no plans to disse­
minate the results of the research directly to study 
participants or the relevant patient community. Disse­
mination to the Swedish population (which constitutes 
the study population) will be through media outreach 
(eg, press release and communication) on publication 
of this study.
results
Fig 1 shows the flow chart of identifying study 
cohorts through the study. The sibling cohort accrued 
2 370 354 person years, with on average eight years 
of follow­up. The mean age at entry to the study was 
37 years (table 1), and 38.3% (39 513/103 072) 
of the individuals with a diagnosed stress related 
disorder were men. A history of other psychiatric 
disorders, severe somatic diseases, and inpatient stay 
for infectious diseases were more common among 
individuals with a diagnosis of a stress related disorder 
than among unaffected full siblings (34.8% v 12.6%, 
16.5% v 12.8%, and 30.9% v 23.8%, respectively). 
In addition, individuals with a diagnosis tended to 
have lower family income and were more likely to be 
divorced or widowed (table 1).
During follow­up, 4843 individuals with incident 
life threatening infections were identified (2197 
among individuals with a diagnosis of a stress related 
disorder and 2646 among unaffected full siblings, with 
a crude incidence rate of 2.7 and 1.7 per 1000 person 
years, respectively). After controlling for all covariates, 
an association was observed between stress related 
disorders and life threatening infections: hazard ratios 
were 1.47 (95% confidence interval 1.37 to 1.58) for 
any stress related disorder, 1.92 (1.46 to 2.52) for PTSD 
(fig 2), 1.43 (1.29 to 1.58) for acute stress reaction, 
and 1.48 (1.33 to 1.64) for adjustment disorder and 
other stress reactions (see supplementary fig 1). Stress 
related disorders were associated with all studied life 
threatening infections, with hazard ratios varying 
from 1.39 (1.16 to 1.65) for deaths due to infections 
of other origin to 1.63 (1.23 to 2.16) for meningitis. 
The population based comparisons corroborated 
these associations (fig 2 and supplementary fig 1) as 
differences between the estimates in the sibling based 
and population based analyses were not significant: 
hazard ratio for any stress related disorder was 1.58 
(1.51 to 1.65), P=0.09 for difference between within 
sibling and population based comparison; hazard 
ratio for PTSD was 1.95 (1.66 to 2.28), P=0.92 for 
difference.
Based on both sibling and population based 
analyses, the observed associations did not differ by 
sex, calendar period, family history of life threatening 
infections, or history of inpatient stay for infectious 
disease (table 2 and supplementary table 2). Asso­
ciations seemed stronger, however, among individuals 
without a history of severe somatic diseases or of other 
psychiatric disorders both (P<0.001 for interaction 
in population based analysis) and within the first 
year after the diagnosis of a stress related disorder 
(P<0.001 for difference in population based analysis). 
Moreover, an age dependent risk pattern suggested a 
linear decline in hazard ratios with increased age at 
diagnosis (fig 3).
Additionally, hazard ratios were higher for any 
stress related disorder diagnosed through inpatient 
hospital care than through outpatient specialist care 
(supplementary table 3, P=0.009 for difference in 
population based analysis). For patients with stress 
related disorders other than PTSD, the presence of 
psychiatric comorbidity, especially comorbid substance 
use disorders, was linked to a further increased relative 
risk of life threatening infections in both sibling and 
population based analyses (supplementary fig 2).
Among individuals with a diagnosis of a stress 
related disorder after July 2005 (n=74 691), the use of 
selective serotonin reuptake inhibitors after diagnosis 
was associated with a lower risk of life threatening 
infections beyond one year (users compared with 
non­users: hazard ratio 0.81 (0.66 to 0.98), P=0.03). 
Persistent use of selective serotonin reuptake inhibitors 
in the first year after diagnosis of a stress related 
disorder was associated with a linear attenuation in the 
relative risk of subsequent life threatening infections 
(hazard ratio 0.96 (0.66 to1.40), 0.85 (0.64 to 1.13), 
and 0.70 (0.52 to0.94) for 179 or less, 180­319, and 
320 days or more of use, respectively, P=0.01 for trend; 
supplementary table 4).
Restricting the analyses to individuals without 
a diagnosis of severe somatic diseases, injury, 
or infectious diseases within one year before the 
index date, or those without anatomical defects, 
yielded largely identical results as the main analyses 
(supplementary tables 5 and 6). Moreover, although 
additional adjustments for severe somatic diseases 
during follow­up did not substantially modify the 
estimates, the hazard ratios, especially those from 
the population based analyses, were attenuated after 
additionally adjusting for the presence of substance 
use or sleep related diagnoses during follow­up 
(supplementary table 7).
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discussion
In this study, individuals with stress related disorders, 
particularly when young at diagnosis, were at increased 
risk of life threatening infections, after taking into 
account sex, familial background, and baseline physical 
or psychiatric conditions. Psychiatric comorbidities, 
especially substance use disorders, were associated 
with further risk increases, whereas the long term 
(>1 year) risk of life threatening infections seemed 
attenuated by persistent use of selective serotonin 
reuptake inhibitors in the first year after diagnosis of a 
stress related disorder.
strengths and weaknesses of this study
The major strength of our study was the use of a 
large population based cohort with complete follow­
up for up to 27 years and the comparison within full 
siblings to tackle the a priori concern about familial 
confounding.17 Information bias was minimised 
because the diagnosis and registration of diagnosis 
and outcome were compiled prospectively and 
independently. Also, because most of the outcomes 
of interest (eg, sepsis, meningitis) are aggressive 
diseases, characterised by sudden onset and severe 
symptoms, the influence of any surveillance bias or 
delayed diagnosis should be minor. Furthermore, the 
large sample size provided enough statistical power 
for detailed subgroup analyses; and the availability 
of rich sociodemographic and medical information 
enabled consideration of a wide range of important 
confounding and mediating factors.
This study has several limitations. Firstly, the late 
establishment of the Swedish Outpatient Register 
(2001) could potentially lead to underestimation of 
people with stress related disorders, especially milder 
forms. Also, changes in the definition and diagnostic 
criteria of stress related disorders over the study period 
could have influenced the observed associations. For 
instance, in 2005 exhaustion disorder was introduced 
to the Swedish ICD­10 system, which resulted in a small 
difference between the Swedish and international ICD­
10 code category F43. Similar results were, however, 
obtained from a subanalysis of different calendar 
periods, suggesting a minor influence of these factors. 
Secondly, we had limited information on some 
important behaviour related factors (eg, smoking, drug 
and alcohol use), and our sensitivity analyses showed 
a considerable mediating effect of these factors on the 
observed associations. Further research with detailed 
data on lifestyle is warranted. Thirdly, although 
trauma focused psychotherapy has been given the 
highest priority for PTSD treatment in many countries, 
including Sweden,22 we have no such data available 
for analyses. Future well designed studies are needed 
for exploring the influence of psychotherapy, alone or 
with drug treatment, on the association between stress 
related disorder and risk of severe infections. Fourthly, 
although the association between stress related 
disorders and risk of fatal infections seems robust, the 
observational nature of our analysis limits inference 
of causality or exploration of potential mediating 
pathways. For instance, despite efforts to control for 
susceptibility to diseases (eg, history of severe somatic 
diseases, other psychiatric disorders, or inpatient 
visit for any infectious diseases) that differ between 
individuals with a diagnosis of a stress related disorder 
and reference groups at baseline, we cannot refute the 
possibility that unmeasured factors contribute to the 
Swedish born residents with new onset stress related disorder
diagnosed between 1 January 1987 and 31 December 2013
1:10 individually matched (sex, birth year, and county of birth)
Siblings entered cohort from diagnosis date of the index individual
Excluded
Diagnosis at age 5 or younger
Major life threatening infections* before onset of stress related disorder
Conflicting information (died or emigrated before diagnosis)
Missing information on birth place






Trackable full siblings on diagnosis date of the index individual
11 618
156 537
Stress related disorder cohort
144 919





No diagnosis of stress related disorder cohort†
1 449 190
Fig 1 | study design. *sepsis, endocarditis, and meningitis or other central nervous system infections. †randomly 
selected from general population: individuals without a diagnosis of stress related disorder or major life threatening 
infection at diagnosis date of the index individual
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reported association. Fifthly, this study only involved 
individuals with a clinical diagnosis of stress related 
disorders through a hospital or specialist visit, thus the 
generalisability of our findings to those with less severe 
stress reaction or daily stress needs further assessment.
comparison with other studies
With few comparable data, our results reinforce the link 
between stress and infection shown in experimental 
studies.4 5 31 32 In the early 1990s, a prospective, 
although non­randomised, study of 394 healthy 
volunteers who received a viral challenge (nasal drops 
containing a low dose of respiratory viruses) after 
questionnaire based psychological stress assessment 
found that psychological stress was associated with an 
increased risk of acute respiratory tract infections in a 
dose­response manner4; and similar conclusions were 
also made in subsequent research.5 31 32 As common 
table 1 | characteristics of study cohorts. values are numbers (percentages) unless stated otherwise
characteristics
sibling cohort Population based cohort








Mean (SD) age at index date (years) 37.0 (13.9) 38.0 (15.1) 37.2 (14.3) 37.2 (14.3)
Mean (SD) follow-up (years) 7.8 (6.4) 8.5 (6.8) 7.9 (6.5) 8.1 (6.6)
Men 39 513 (38.3) 94 163 (51.0) 55 541 (38.3) 555 410 (38.3)
Education level (years):
 <9 4191 (4.1) 11 919 (6.5) 6453 (4.4) 58 565 (4.0)
 9-12 73 505 (71.3) 126 305 (68.4) 103 252 (71.3) 941 393 (65.0)
 >12 23 839 (23.1) 41 569 (22.5) 32 625 (22.5) 426 442 (29.4)
 Unknown 1537 (1.5) 4819 (2.6) 2589 (1.8) 22 790 (1.6)
Yearly family income level:
 Lowest 20% 22 941 (22.3) 33 782 (18.3) 32 847 (22.7) 247 467 (17.1)
 Middle 56 877 (55.2) 95 927 (52.0) 79 051 (54.6) 799 409 (55.2)
 Top 20% 13 160 (12.8) 29 946 (16.2) 18 292 (12.6) 254 009 (17.5)
 Unknown 10 094 (9.8) 24 957 (13.5) 14 729 (10.2) 148 305 (10.2)
Marital status:
 Single 58 791 (57.0) 100 525 (54.5) 82 425 (56.9) 823 667 (56.8)
 Married or cohabiting 30 730 (29.8) 66 694 (36.1) 42 868 (29.6) 514 251 (35.5)
 Divorced or widowed 13 551 (13.2) 17 393 (9.4) 19 626 (13.5) 111 272 (7.7)
History of severe somatic diseases†:
 Yes 17 020 (16.5) 23 534 (12.8) 24 004 (16.6) 145 619 (10.1)
 No 86 052 (83.5) 161 078 (87.3) 120 915 (83.4) 1 303 571 (90.0)
History of other psychiatric disorders‡:
 Yes 36 202 (34.8) 23 466 (12.6) 51 905 (35.8) 118 910 (8.2)
 No 67 860 (65.2) 162 605 (87.4) 93 014 (64.2) 1 330 280 (91.8)
Family history of major life threatening infections:
 Yes 10 992 (10.7) 20 455 (11.1) 15 548 (10.7) 134 214 (9.3)
 No 92 080 (89.3) 164 157 (88.9) 129 371 (89.3) 1 314 976 (90.7)
History of inpatient visit for infectious diseases:
 Yes 31 836 (30.9) 43 956 (23.8) 46 269 (31.9) 307 370 (21.2)
 No 71 236 (69.1) 140 656 (76.2) 98 750 (68.1) 1 141 820 (78.8)
Type of stress related disorders:
 Post-traumatic stress disorder 8105 (7.8) - 11 541 (7.9) -
 Acute stress reaction 47 195 (45.8) - 66 758 (46.1) -
 Adjustment disorder and other stress reaction 47 772 (46.4) - 66 620 (46.0) -
Type of psychiatric care received at diagnosis:
 Inpatient 37 352 (36.2) - 52 817 (36.5) -
 Outpatient 65 720 (63.8) - 92 102 (63.5) -
Psychiatric comorbidity§:
 Any
 Yes 22 619 (21.9) - 31 415 (21.7) -
 No 80 453 (78.1) - 113 504 (78.3) -
Depression:
 Yes 10 581(10.3) - 14 500 (10.0) -
 No 92 491(89.7) - 130 419 (90.0) -
Anxiety:
 Yes 6683 (6.5) - 9222 (6.4) -
 No 96 389 (93.5) - 135 697 (93.6) -
Substance use disorder:
 Yes 4567 (4.4) - 6514 (4.5) -
 No 98 505 (95.6) - 138 405 (95.5) -
*Matched individuals without a diagnosis of stress related disorder.
†Myocardial infarction, congestive heart failure, cerebrovascular disease, chronic pulmonary disease, connective tissue disease, dementia, diabetes, renal diseases, liver diseases, ulcer diseases, 
and HIV infection/AIDS.
‡First diagnosis of a psychiatric disorder, other than stress related disorders, occurring more than three months before index date (ie, diagnosis date for individuals with stress related disorder, or 
diagnosis date of index patient for matched individuals and siblings without a diagnosis of stress related disorder).
§New onset psychiatric disorder, other than stress related disorders, diagnosed from three months before to one year after diagnosis of stress related disorder.
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respiratory viral infections were the predominant 
disease models in the investigations, however, it 
remains unclear whether the stress induced immune 
modulation leads to more severe infection related 
consequences.
Consistent with our findings, one recent Danish 
register based study, involving 4984 patients with 
PTSD diagnosed between 1995 and 2011, reported an 
association between PTSD and 34 types of infectious 
diseases, including infections of central nervous 
system.16 Also, one cohort study33 indicated that a 
higher perceived stress level was moderately associated 
with one year and 10 year risk of sepsis in a sample 
of 30 183 community dwelling adults aged 45 years 
or older in the United States. Although these results 
were suggestive, these studies were either focused 
on PTSD only or based on one time measurement 
of psychological stress in an older population, with 
limited observed incident cases of severe infections 
and little control of familial and comorbidity factors.
Meaning of the study
With a specific focus on clinically diagnosed stress 
related disorders, we show that severe stress reactions, 
even transient ones (eg, acute stress reaction), were 
associated with an increased risk of life threatening 
infections, both in the short and in the long term. 
Importantly, the observed excess risks remained after 
controlling for most of the known risk factors of the 
studied infections,34­36 such as socioeconomic factors, 
Sibling based analysis
  Any stress related disorder
    Life threatening infections
    Sepsis
    Endocarditis
    Meningitis
    Other CNS infections
    Death due to other infections
  Post-traumatic stress disorder
    Life threatening infections
    Sepsis
    Endocarditis
    Meningitis
    Other CNS infections
    Death due to other infections
Population based analysis
  Any stress related disorder
    Life threatening infections
    Sepsis
    Endocarditis
    Meningitis
    Other CNS infections
    Death due to other infections
  Post-traumatic stress disorder
    Life threatening infections
    Sepsis
    Endocarditis
    Meningitis
    Other CNS infections
    Death due to other infections
































1.47 (1.37 to 1.58)
1.52 (1.39 to 1.66)
1.57 (1.08 to 2.30)
1.63 (1.23 to 2.16)
1.45 (1.21 to 1.73)
1.39 (1.16 to 1.65)
1.92 (1.46 to 2.52)
1.84 (1.30 to 2.61)
5.38 (0.46 to 62.9)
3.03 (0.63 to 14.6)
1.90 (0.85 to 4.24)
1.85 (0.89 to 3.83)
1.58 (1.51 to 1.65)
1.61 (1.52 to 1.70)
1.89 (1.55 to 2.32)
1.70 (1.43 to 2.02)
1.58 (1.41 to 1.76)
1.64 (1.48 to 1.81)
1.95 (1.66 to 2.28)
2.01 (1.65 to 2.45)
2.90 (1.46 to 5.76)
2.80 (1.49 to 5.26)
1.88 (1.23 to 2.87)
1.99 (1.37 to 2.90)
Hazard ratio
(95% CI)
Fig 2 | crude incidence and hazard ratios (95% confidence intervals) for life threatening infections among individuals with any stress related 
disorder and post-traumatic stress disorder (exposed) compared with full siblings or matched individuals without such a diagnosis (unexposed). 
*cox models were stratified by family identifiers and adjusted for sex, birth year, education level, family income, marital status, and history of 
severe somatic diseases, other psychiatric disorder, and inpatient visit for infectious diseases. †cox models were stratified by matching identifiers 
(sex, birth year, and county of birth) and adjusted for education level; family income; marital status; history of severe somatic diseases, other 
psychiatric disorder, and inpatient visit for infectious diseases; and family history of major life threatening infections. cns=central nervous system
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familial background, physical conditions at baseline 
(including baseline susceptibility to infection), and 
the occurrence of other severe somatic diseases 
during follow­up. Although relatively rare, severe 
infections contribute substantially to the global bur­
den of disease because of high fatality, risk of long 
term complications, and high healthcare costs.37 38 In 
contrast, stress related disorders are common in the 
general population. The reported lifetime prevalence 
of PTSD in Sweden was 5.6% in 2005,39 and our data 
suggest at least a 10 times higher prevalence for other 
stress related disorders, underscoring the considerable 
clinical significance and public health implications of 
our findings.
Initial attempts at explaining the documented 
association between stress and infection were 
concentrated on altered circulating glucocorticoid 
levels and the role these played in suppression of cell 
mediated and humoral immunity,40 41 which could 
potentially increase vulnerability to infections among 
stressed individuals. Yet studies testing the association 
between glucocorticoid levels and risk of infections 
produced mixed results.42­45 A recent hypothesis 
places focus on the underlying inflammation, where 
glucocorticoid receptor resistance results in over­
production of inflammatory cytokines.6 46 This notion 
gains support from several studies, including the 
present one, implying that traumatic stress may 
exacerbate the severity of future infections.4 47
Alternative explanations for the impact of severe 
stress reactions on life threatening infection include 
behaviour related changes after the diagnosis of a stress 
related disorder. In the present study we observed a 
further increased relative risk among individuals with a 
diagnosis of stress related disorders and with comorbid 
substance use disorders, as well as attenuated excess 
risk after additionally adjusting for substance use and 
sleep related diagnoses during follow­up. It is therefore 
possible that behavioural factors (eg, smoking, alcohol 
or drug use, and sleep disturbance) at least partially 
mediate the observed association, through increased 
possibility of exposure to pathogens (eg, needle 
sharing among drug users48) or inducing immune 
dysfunction, or both.49 Nevertheless, it is unlikely that 
such behavioural factors can fully explain the increase 
in fatal infection related consequences, especially 
those that appear shortly after a diagnosis of stress 
related disorder.
Our finding suggesting that a diagnosis of stress 
related disorders in early life is associated with 
the largest relative risk increase in life threatening 
infections is in line with findings showing that 
childhood exposure to trauma might have a lifelong 
impact on susceptibility to disease, through pro­
table 2 | Hazard ratios (95% confidence intervals) for life threatening infections among individuals with any stress related disorder compared with full 
siblings or matched unexposed individuals, by characteristics
characteristics
no of cases (incidence per 1000 person years): sibling 
based analysis










no stress related 
disorder cohort
Hazard ratio  
(95% ci)†
Sex:
 Men 983 (3.11) 1500 (1.89) 1.44 (1.26 to 1.64) 1444 (3.29) 7034 (1.52) 1.57 (1.47 to 1.67)
 Women 1214 (2.44) 1146 (1.48) 1.41 (1.24 to 1.59) 1848 (2.66) 8650 (1.22) 1.59 (1.50 to 1.68)
Time since index date (years):
 <1 266 (2.71) 230 (1.30) 1.61 (1.30 to 2.00) 410 (2.98) 1438 (1.04) 2.04 (1.81 to 2.30)
 1-4 723 (2.34) 805 (1.42) 1.53 (1.36 to 1.73) 1045 (2.43) 5053 (1.16) 1.45 (1.35 to 1.56)
 5-9 543 (2.45) 694 (1.64) 1.35 (1.18 to 1.54) 811 (2.64) 3941 (1.25) 1.51 (1.39 to 1.65)
 ≥10 665 (3.59) 917 (2.30) 1.50 (1.32 to 1.70) 1026 (3.99) 5252 (1.88) 1.65 (1.53 to 1.78)
History of severe somatic diseases‡:
 Yes 676 (5.66) 663 (3.92) 1.37 (1.06 to 1.76) 1044 (6.09) 3452 (3.40) 1.38 (1.23 to 1.56)
 No 1521 (2.19) 1983 (1.42) 1.49 (1.37 to 1.62) 2248 (2.34) 12 232 (1.14) 1.65 (1.57 to 1.73)
Calendar year at index date:
 1987-2000 1019 (2.82) 1330 (1.72) 1.51 (1.37 to 1.67) 1564 (3.10) 7401 (1.39) 1.66 (1.56 to 1.77)
 2001-05 696 (2.52) 833 (1.69) 1.31 (1.16 to 1.48) 1035 (2.70) 5183 (1.34) 1.45 (1.34 to 1.57)
 2006-13 482 (2.74) 483 (1.60) 1.64 (1.43 to 1.88) 693 (2.81) 3100 (1.25) 1.60 (1.48 to 1.74)
History of other psychiatric disorders§:
 Yes 967 (4.09) 576 (3.86) 1.25 (1.01 to 1.56) 1465 (4.33) 2308 (3.44) 1.26 (1.12 to 1.41)
 No 1230 (2.13) 2070 (1.46) 1.58 (1.45 to 1.73) 1827 (2.30) 13 376 (1.21) 1.79 (1.70 to 1.88)
Family history of major life threatening infec-
tions:
 Yes 219 (3.47) 248 (1.99) 1.51 (1.20 to 1.89) 300 (3.43) 1259 (1.64) 1.81 (1.39 to 2.37)
 No 1978 (2.64) 2398 (1.66) 1.38 (1.28 to 1.48) 2992 (2.86) 14 425 (1.32) 1.60 (1.53 to 1.67)
History of inpatient stay for infectious diseases:
 Yes 931 (3.94) 812 (2.50) 1.25 (1.03 to 1.50) 1405 (4.14) 4321 (2.04) 1.52 (1.39 to 1.66)
 No 1266 (2.19) 1834 (1.48) 1.58 (1.44 to 1.74) 1887 (2.38) 11 363 (1.19) 1.69 (1.60 to 1.78)
*Cox models were stratified by family identifiers and adjusted for sex, birth year, education level, family income, marital status, and history of severe somatic diseases, other psychiatric disorder, 
and inpatient visit for infectious disease.
†Cox models were stratified by matching identifiers (sex, birth year, and county of birth) and adjusted for education level; family income; marital status; history of severe somatic diseases, other 
psychiatric disorder, and inpatient visit for infectious diseases; and family history of major life threatening infections.
‡Myocardial infarction, congestive heart failure, cerebrovascular disease, chronic pulmonary disease, connective tissue disease, dementia, diabetes, renal diseases, liver diseases, ulcer diseases, 
and HIV infection/AIDS.
§First diagnosis of a psychiatric disorder, other than stress related disorders, occurring more than three months before index date.
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moting inflammatory reactions,50 51 interrupting 
neuropsychological and cognitive development,52 53 
or an interplay between genes and the environment.54 
Indeed, the extent of epigenetic modifications, 
measured as frequency of DNA methylation changes, 
were up to 12 times higher in participants with PTSD 
who were exposed to trauma in childhood compared 
with participants with PTSD who were trauma­free 
in childhood.54 These results constitute a molecular 
basis implying potentially more extensive biological 
disruptions and thereby potentially worse health 
outcomes for younger, rather than older, people with 
stress related disorders.
conclusions
In this study, clinically diagnosed stress related 
disorders were associated with an increased risk of 
life threatening infections in the Swedish population. 
Despite a relatively low absolute risk, the high mortality 
from life threatening infections calls for increased 
clinical awareness among health professionals caring 
for patients with stress related disorders, especially 
those diagnosed at younger age. In addition, our 
findings, subject to replication, suggest an attenuation 
in the relative risk of life threatening infections with 
use of selective serotonin reuptake inhibitors. Further 
studies are needed to understand the potential 
mediating role of behaviour related factors in the 
observed association as well as potential mitigating 
role of various treatments for stress related disorders in 
reducing the excess risk of life threatening infections.
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Fig 3 | association between stress related disorders and life threatening infections by 
age at index date. *restricted cubic splines were applied on age at index date, with 
five knots placed at 5, 27.5, 50, 72.5, and 95 quantiles of the distribution of outcome 
events. age varying hazard ratios were then predicted based on fully adjusted cox 
models where interaction terms between stress related disorders and splined age 
profiles were added. in sibling based analysis, the cox models were stratified by family 
identifiers and adjusted for sex, birth year, education level, family income, marital 
status, and history of severe somatic diseases, inpatient visit for infectious diseases, 
and other psychiatric disorder. in population based analysis, the cox models were 
stratified by matching identifiers—that is, sex, birth year, and county of birth, and 
adjusted for education level; family income; marital status; history of severe somatic 
diseases, inpatient visit for infectious diseases, and other psychiatric disorders; 
and family history of major life threatening infections. shaded area represents 95% 
confidence intervals
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